Moderna Inc said on Tuesday that its Covid-19 vaccine still showed strong protection against the illness six months after people received their second shot, with efficacy of more than 90 percent against all cases of Covid-19 and more than 95 percent against severe Covid-19. The vaccine maker, which will be updating investors on the progress of its vaccines at an event on